Why the study?
Does multivessel PCI reduce all-cause readmission and major adverse cardiovascular events in patients with acute myocardial infarction and multivessel disease?
Does multivessel PCI reduce all-cause readmission and major adverse cardiovascular events in patients with acute myocardial infarction and multivessel disease?
In patients with acute MI and multivessel disease, an observational analysis suggests multivessel PCI is associated with reduced short-term readmissions and up to 1-year MACE compared to culprit-only PCI, without significant differences in angina burden.
Answers are grounded in this paper and cite their sources.
May reduce early readmissions and MACE after acute MI; hypothesis-generating and requires randomized confirmation before practice change.
Among patients with acute MI who have multivessel disease, multivessel PCI was associated with lower risk of all-cause readmission at 6 weeks and lower risk of major adverse cardiovascular events at 6 weeks and 1 year. However, similar short- and long-term angina frequencies were noted.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: